Image provided by JSNC

The US and Japan have adopted very different approaches to responding to the COVID-19 pandemic, including on testing, tracking, social distancing, procurement of medical materials and devices and treatment of the illness.  We will know in the next weeks how successful these varying approaches have been. 

Please join Japan Society of Northern California (JSNC) for a webinar on April 28 to listen to two medical doctors from Stanford discuss the different approaches that the US and Japan have taken, with reference to the strategies taken in China, Taiwan and South Korea; the results so far in countering the virus; what we can learn from each other; and prospects for containing the virus and restarting economic activity.  The speakers are individuals with deep expertise in health care and medical devices, but who can speak plain lay language to demystify the complicated issues that COVID-19 raises.

This webinar is free and open to the public with registration.

Click on the button below to register:

About the Speakers:

Bryant Lin is a clinical associate professor for medicine in the area of primary care and population health at Stanford. He is also Co-Director of Stanford’s Center for Asia Health Research and Education.

Fumiaki Ikeno is a Research Associate of Cardiovascular Medicine at Stanford University where he is responsible for pre clinical studies for medical devices and regenerative medicines for cardiovascular diseases. Dr. Ikeno has deep connections to early stage medtech companies in Silicon Valley and Japan and is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.

Cho-Wei “Jowy” Chen, is the CEO of Taipei Medical University Biomedical Accelerator. He is also a Global Faculty Fellow, Stanford Byers Center for Biodesign.

Biographies provided by JSNC